<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tpst-20241203.xsd" xlink:type="simple"/>
    <context id="duration_2024-12-03_to_2024-12-03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001544227</identifier>
        </entity>
        <period>
            <startDate>2024-12-03</startDate>
            <endDate>2024-12-03</endDate>
        </period>
    </context>
    <context id="duration_2024-12-03_to_2024-12-03_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001544227</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-03</startDate>
            <endDate>2024-12-03</endDate>
        </period>
    </context>
    <context id="duration_2024-12-03_to_2024-12-03_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001544227</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-03</startDate>
            <endDate>2024-12-03</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2024-12-03_to_2024-12-03" id="ixv-304">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-12-03_to_2024-12-03"
      id="Hidden_dei_EntityCentralIndexKey">0001544227</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2024-12-03_to_2024-12-03" id="ixv-331">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-12-03_to_2024-12-03" id="ixv-332">2024-12-03</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2024-12-03_to_2024-12-03" id="ixv-333">TEMPEST THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-12-03_to_2024-12-03" id="ixv-334">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-12-03_to_2024-12-03" id="ixv-335">001-35890</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-12-03_to_2024-12-03" id="ixv-336">45-1472564</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-12-03_to_2024-12-03" id="ixv-337">2000 Sierra Point Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2024-12-03_to_2024-12-03" id="ixv-338">Suite 400</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-12-03_to_2024-12-03" id="ixv-339">Brisbane</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-12-03_to_2024-12-03" id="ixv-340">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-12-03_to_2024-12-03" id="ixv-341">94005</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-12-03_to_2024-12-03" id="ixv-342">(415)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-12-03_to_2024-12-03" id="ixv-343">798-8589</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-12-03_to_2024-12-03" id="ixv-344">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-12-03_to_2024-12-03" id="ixv-345">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-12-03_to_2024-12-03" id="ixv-346">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-12-03_to_2024-12-03" id="ixv-347">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="duration_2024-12-03_to_2024-12-03_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="ixv-348">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2024-12-03_to_2024-12-03_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="ixv-349">TPST</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2024-12-03_to_2024-12-03_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="ixv-350">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2024-12-03_to_2024-12-03_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember"
      id="ixv-351">Series A Junior Participating Preferred Purchase Rights</dei:Security12bTitle>
    <dei:SecurityExchangeName
      contextRef="duration_2024-12-03_to_2024-12-03_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember"
      id="ixv-352">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-12-03_to_2024-12-03" id="ixv-353">false</dei:EntityEmergingGrowthCompany>
</xbrl>
